Goldman Sachs raised the firm’s price target on Shoulder Innovations (SI) to $20 from $19 and keeps a Buy rating on the shares. After a year when fundamentals diverged from stock performance, 2026 should represent a return to normalized patterns where organic growth defines relative valuation, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SI:
- Shoulder Innovations Partners with Interventional Systems
- Shoulder Innovations partners with INS for robotic surgical platform
- Shoulder Innovations price target raised to $23 from $18 at Morgan Stanley
- Promising Outlook for Shoulder Innovations, Inc.: Buy Rating Affirmed by Patrick Wood
- Shoulder Innovations Reports Strong Q3 Growth and Raises Guidance